JPWO2023159120A5 - - Google Patents
Info
- Publication number
- JPWO2023159120A5 JPWO2023159120A5 JP2024546431A JP2024546431A JPWO2023159120A5 JP WO2023159120 A5 JPWO2023159120 A5 JP WO2023159120A5 JP 2024546431 A JP2024546431 A JP 2024546431A JP 2024546431 A JP2024546431 A JP 2024546431A JP WO2023159120 A5 JPWO2023159120 A5 JP WO2023159120A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- pharmaceutical composition
- administration period
- alkyl
- counts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263310751P | 2022-02-16 | 2022-02-16 | |
| US63/310,751 | 2022-02-16 | ||
| PCT/US2023/062731 WO2023159120A1 (en) | 2022-02-16 | 2023-02-16 | Certain n-(1-cyano-2-phenylethyl)-1,4-oxazepane-2-carboxamides for treating hidradenitis suppurativa |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025508359A JP2025508359A (ja) | 2025-03-26 |
| JP2025508359A5 JP2025508359A5 (https=) | 2026-02-19 |
| JPWO2023159120A5 true JPWO2023159120A5 (https=) | 2026-02-19 |
Family
ID=87579133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024546431A Pending JP2025508359A (ja) | 2022-02-16 | 2023-02-16 | 化膿性汗腺炎を治療するためのある特定のｎ－（１－シアノ－２－フェニルエチル）－１，４－オキサゼパン－２－カルボキサミド |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250144116A1 (https=) |
| EP (1) | EP4479059A4 (https=) |
| JP (1) | JP2025508359A (https=) |
| KR (1) | KR20240148350A (https=) |
| CN (1) | CN118695864A (https=) |
| AU (1) | AU2023221393A1 (https=) |
| CA (1) | CA3244131A1 (https=) |
| GB (1) | GB2630719A (https=) |
| IL (1) | IL314769A (https=) |
| MX (1) | MX2024009995A (https=) |
| WO (1) | WO2023159120A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO2699580T3 (https=) | 2014-01-24 | 2018-02-24 | ||
| KR20250002710A (ko) | 2018-03-01 | 2025-01-07 | 아스트라제네카 에이비이 | (2s)-n-｛(1s)-1-시아노-2-[4-(3-메틸-2-옥소-2,3-디하이드로-1,3-벤족사졸-5-일)페닐]에틸｝-1,4-옥사제판-2-카복스아미드를포함하는 약학 조성물 |
| AU2019306532A1 (en) | 2018-07-17 | 2021-03-04 | Insmed Incorporated | Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating Lupus Nephritis |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO2699580T3 (https=) * | 2014-01-24 | 2018-02-24 | ||
| KR20250107292A (ko) * | 2016-07-29 | 2025-07-11 | 인스메드 인코포레이티드 | 기관지확장증을 치료하기 위한 특정 (2s)-n-[(1s)-1-시아노-2-페닐에틸]-1,4-옥사제판-2-카르복스아미드 |
| AU2019217870A1 (en) * | 2018-02-07 | 2020-08-27 | Insmed Incorporated | Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating ANCA associated vasculitides |
| WO2020214855A1 (en) * | 2019-04-17 | 2020-10-22 | Azora Therapeutics, Inc. | Topical compositions and methods for treating inflammatory skin diseases |
| EP4561565A2 (en) * | 2022-07-28 | 2025-06-04 | Insmed Incorporated | Novel dpp1 inhibitors and uses thereof |
-
2023
- 2023-02-16 EP EP23757082.5A patent/EP4479059A4/en active Pending
- 2023-02-16 CN CN202380021843.7A patent/CN118695864A/zh active Pending
- 2023-02-16 MX MX2024009995A patent/MX2024009995A/es unknown
- 2023-02-16 GB GB2412566.8A patent/GB2630719A/en active Pending
- 2023-02-16 WO PCT/US2023/062731 patent/WO2023159120A1/en not_active Ceased
- 2023-02-16 CA CA3244131A patent/CA3244131A1/en active Pending
- 2023-02-16 AU AU2023221393A patent/AU2023221393A1/en active Pending
- 2023-02-16 JP JP2024546431A patent/JP2025508359A/ja active Pending
- 2023-02-16 KR KR1020247027154A patent/KR20240148350A/ko active Pending
- 2023-02-16 IL IL314769A patent/IL314769A/en unknown
- 2023-02-16 US US18/838,823 patent/US20250144116A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI225398B (en) | Composition for treatment of external secretion disorders | |
| JP2023002662A5 (https=) | ||
| JP2025013344A5 (https=) | ||
| JP2022191257A5 (https=) | ||
| JP2021530513A5 (https=) | ||
| JP2008521827A5 (https=) | ||
| CN1107706A (zh) | 抑制皮脂溢和痤疮的方法 | |
| RU2014132564A (ru) | Хитозан, ковалентно связанный с низкомолекулярным антагонистом интегрина, для нацеленной доставки | |
| JP2025508359A (ja) | 化膿性汗腺炎を治療するためのある特定のｎ－（１－シアノ－２－フェニルエチル）－１，４－オキサゼパン－２－カルボキサミド | |
| JP2018203774A (ja) | 精神障害の治療における使用のためのイロペリドン代謝物 | |
| JPH0575729B2 (https=) | ||
| CN1859948B (zh) | 促进唾液分泌的喹诺酮衍生物 | |
| JPWO2023159120A5 (https=) | ||
| JP2022177119A5 (https=) | ||
| US5658950A (en) | Therapeutic agent for glaucoma and ocular hypotensive agent | |
| JPWO2020018551A5 (https=) | ||
| JPWO2023076615A5 (https=) | ||
| JPH10298077A (ja) | 心筋症の治療、予防剤 | |
| JP2007513173A (ja) | ロシグリタゾンを用いる乾癬の治療 | |
| RU2342133C2 (ru) | Применение производных феноксиуксусной кислоты для лечения гиперактивности мочевого пузыря | |
| JP2005511571A5 (https=) | ||
| BR112012000410B1 (pt) | uso de benzidamina ou dos sais de adição de ácido, e, composição farmacêutica | |
| JPWO2020037152A5 (https=) | ||
| WO2009080693A2 (en) | Pharmaceutical composition comprising tesofensine or its analogue and a beta blocker | |
| JPWO2022086958A5 (https=) |